acetaminofen 300 mg, supositorio, vía rectal
neoethicals, s.a. - acetaminofÉn - acetaminofÉn....300 mg.
ketoconazol crema 2 %
neoethicals, s.a. - ketoconazol - ketoconazol....20mg
fluconazol 150 mg capsulas
neoethicals, s.a. - fluconazol - fluconazol....150 mg
secnidazol 500 mg tabletas recubiertas
neoethicals, s.a. - secnidazol - secnidazol....500 mg.
ecoporc shiga
ceva santé animale - genetically modified recombinant shiga-toxin-2e antigen - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - pigs - active immunisation of piglets from the age of four days, to reduce the mortality and clinical signs of oedema disease caused by shiga toxin 2e produced by escherichia coli (stec). onset of immunity: 21 days after vaccination. duration of immunity: 105 days after vaccination.,
gran injection 150 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グラン注射液150[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])
kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection
gran injection 75 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グラン注射液75[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])
kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection
gran injection m300 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グラン注射液m300[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])
kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection
gran syringe 150 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グランシリンジ150[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])
kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection
gran syringe 75 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グランシリンジ75[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])
kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection